These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23082931)

  • 1. Multinational study of oestrogen and progesterone receptor immunocytochemistry on breast carcinoma fine needle aspirates.
    Marinšek ZP; Nolde N; Kardum-Skelin I; Nizzoli R; Onal B; Rezanko T; Tani E; Ostović KT; Vielh P; Schmitt F; Kocjan G
    Cytopathology; 2013 Feb; 24(1):7-20. PubMed ID: 23082931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the oestrogen and progesterone receptor status in primary breast carcinomas as evaluated by immunohistochemistry and immunocytochemistry: a consecutive series of 267 patients.
    Domanski AM; Monsef N; Domanski HA; Grabau D; Fernö M
    Cytopathology; 2013 Feb; 24(1):21-5. PubMed ID: 22783929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears.
    Krishnamurthy S; Dimashkieh H; Patel S; Sneige N
    Diagn Cytopathol; 2003 Dec; 29(6):309-14. PubMed ID: 14648786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine needle aspirate cell blocks are reliable for detection of hormone receptors and HER-2 by immunohistochemistry in breast carcinoma.
    Bueno Angela SP; Viero RM; Soares CT
    Cytopathology; 2013 Feb; 24(1):26-32. PubMed ID: 22220518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stability of estrogen and progesterone receptor expression on breast carcinoma cells stored as PreservCyt suspensions and as ThinPrep slides.
    Tabbara SO; Sidawy MK; Frost AR; Brosky KR; Coles V; Hecht S; Radcliffe G; Sherman ME
    Cancer; 1998 Dec; 84(6):355-60. PubMed ID: 9915137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries.
    Rhodes A; Jasani B; Balaton AJ; Miller KD
    J Clin Pathol; 2000 Apr; 53(4):292-301. PubMed ID: 10823126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ER, PR, and Her2 immunocytochemistry on cell-transferred cytologic smears of primary and metastatic breast carcinomas: a comparison study with formalin-fixed cell blocks and surgical biopsies.
    Ferguson J; Chamberlain P; Cramer HM; Wu HH
    Diagn Cytopathol; 2013 Jul; 41(7):575-81. PubMed ID: 22807465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
    Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories.
    Regitnig P; Reiner A; Dinges HP; Höfler G; Müller-Holzner E; Lax SF; Obrist P; Rudas M; Quehenberger F
    Virchows Arch; 2002 Oct; 441(4):328-34. PubMed ID: 12404057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
    Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
    Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry.
    Radhika K; Prayaga AK
    Indian J Cancer; 2010; 47(2):148-50. PubMed ID: 20448377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen, progesterone, and HER-2 receptor immunostaining in cytology: the effect of varied fixation on human breast cancer cells.
    Maleki S; Dorokhova O; Sunkara J; Schlesinger K; Suhrland M; Oktay MH
    Diagn Cytopathol; 2013 Oct; 41(10):864-70. PubMed ID: 23447357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization and validation of immunocytochemical detection of oestrogen receptors on cytospins prepared from fine needle aspiration (FNA) samples of breast cancer.
    Srebotnik Kirbiš I; Us Krašovec M; Pogačnik A; Strojan Fležar M
    Cytopathology; 2015 Apr; 26(2):88-98. PubMed ID: 24807705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistochemical determination of hormonal receptors on cell-blocks from fine-needle cytopunctures of breast carcinoma].
    Briffod M; Le Doussal V; Spyratos F
    Bull Cancer; 2001 Oct; 88(10):1028-35. PubMed ID: 11713039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer.
    Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A
    Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemistry for oestrogen receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma.
    Kumar SK; Gupta N; Rajwanshi A; Joshi K; Singh G
    Cytopathology; 2012 Jun; 23(3):181-6. PubMed ID: 21375607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma.
    Gong Y; Symmans WF; Krishnamurthy S; Patel S; Sneige N
    Cancer; 2004 Feb; 102(1):34-40. PubMed ID: 14968416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of oestrogen and progesterone receptors on fine-needle aspirates and cryostat sections of breast carcinomas: how does this compare with biochemical assays?
    Muchiri LW
    East Afr Med J; 1993 May; 70(5):280-3. PubMed ID: 8306903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytologic evaluation of prognostic markers in breast carcinoma.
    Jayaram G; Elsayed EM
    Acta Cytol; 2005; 49(6):605-10. PubMed ID: 16450899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions.
    Kandil D; Leiman G; Allegretta M; Trotman W; Pantanowitz L; Goulart R; Evans M
    Cancer; 2007 Oct; 111(5):316-22. PubMed ID: 17763368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.